Cannabis Investment Report lists global medical/recreational legal status
Summary
The document is a generic market overview with no specific individuals, transactions, dates, or allegations. It provides no actionable leads linking powerful actors to misconduct or controversy. Lists countries with medical or recreational cannabis laws as of 2017 Notes potential future recreational law in Canada (mid‑2018) Mentions Uruguay having both medical and recreational frameworks
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Cannabis Investment Report – Market Size Projections and Legal Landscape (Dec 2017)
The document is a generic industry market report with no specific individuals, transactions, or allegations. It contains broad market forecasts and legal status summaries, offering no actionable inves Projects U.S. legal cannabis market to exceed $100 billion annually. Estimates global legal market potential at $500 billion annually. Notes 29 U.S. states permit medical cannabis despite federal pro
Ackrell Capital Cannabis Investment Report compares market size to alcohol, coffee, tobacco, and pharmaceuticals
The document is a commercial investment analysis with no mention of political figures, government agencies, or alleged misconduct. It offers no actionable leads for investigations and contains only pu Provides estimated penetration rates and consumer spending for cannabis versus other legal substance Claims U.S. legal cannabis market size aligns with other retail markets. Published by Ackrell Capi
Cannabis Investment Report – Private Company Funding Totals (2016‑2017 YTD)
The document lists aggregate capital raised by private cannabis‑related firms and a few deal specifics. It contains no references to high‑ranking officials, government agencies, foreign leaders, or al Total capital raised by private cannabis companies grew from $256 M in 2016 to $483 M YTD 2017. Number of deals increased from 65 to 102 in the same period. Largest disclosed private deals in 2017 we
Cannabis Investment Report – Industry Overview, No Specific Leads
The document is a generic market analysis of the cannabis sector with no mention of specific individuals, transactions, or wrongdoing. It provides background context but offers no actionable investiga Describes capital needs for multi‑jurisdiction facilities due to federal restrictions. Notes potential for large agricultural firms to enter the market if laws relax. Outlines distribution sub‑segmen
Cannabis Investment Report lists federal statutes and agency responsibilities
The passage merely enumerates existing federal laws, regulations, and agencies relevant to the cannabis industry. It contains no specific allegations, names, transactions, or novel information linking Lists the Controlled Substances Act, DEA, DOJ, Treasury, FinCEN, and other statutes. Identifies the Cole Memo, Rohrabacher-FinCEN Memo, and related policy documents. Provides a high‑level overview of
Ackrell Capital Cannabis Investment Report – Technical Overview of Cannabis Genetics (Dec 2017)
The passage provides a technical summary of cannabis breeding and genome mapping with no mention of high‑profile individuals, financial misconduct, or controversial political actions. It lacks actiona Describes breeding methods: clone clipping and tissue culture. Notes first cannabis genome mapping in 2011 by Canadian researchers. Mentions potential IP issues and a U.S. patent for a cannabis strai
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.